most popular glp-1 drugs List of approved and pending medications Americans are taking weight-loss drugs

New analyses involving more than 100,000 patients suggest that users of popular diabetes and weight-loss medications face a lower risk of developing certain cancers and a reduced risk of metastasis.

In 2024, we also saw unprecedented willingness by large numbers of patients to pay out of pocket, even in European markets, as public coverage of AOMs is still limited, at best, and more often non-existent

This article examines clinical evidence for combination therapy, safety profiles, and how genetic predispositions in GLP-1 and glucose metabolism pathways may info

Learn more.

(2025) explores current evidence, challenges, and future perspectives in managing surgical patients on GLP-1R agonists

| 228 comments on LinkedIn